114457-94-2
114457-94-2
Chemical Structure
Antibacterial agent 268
- CAS No.: 114457-94-2
- Formula:C14H13N3O3
- Molecular Weight:271.28
IUPAC Name: (pyrazine-2-carbonyl)-L-phenylalanine
InChIKey: DWYZPDHMMZGQAP-NSHDSACASA-N
SMILES: O=C(O)[C@H](CC1=CC=CC=C1)NC(C2=NC=CN=C2)=O
Biological Activity: Antibacterial agent 268 (Compound 10e) is an antibacterial agent with antimycobacterial properties. Antibacterial agent 268 shows high anti-bacterial properties at sub-micromolar values (MIC=0.44-0.07 μM)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Antibacterial agent 268 | 99.74% | Antibacterial agent 268 (Compound 10e) is an antibacterial agent with antimycobacterial properties. Antibacterial agent 268 shows high anti-bacterial properties at sub-micromolar values (MIC=0.44-0.07 μM). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bortezomib (Standard) | 99.73% | Bortezomib (Standard) is the analytical standard of Bortezomib. This product is intended for research and analytical applications. Bortezomib (PS-341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0.6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-κB. Bortezomib is the first proteasome inhibitor anticancer agent. Bortezomib can be used for the study of multiple myeloma (MM). Bortezomib effectively inhibits TREM2 expression in tumor-associated macrophages (TAMs). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Benzoyl-L-phenylalanine | 99.68% | Benzoyl-L-phenylalanine (N-Benzoyl-L-phenylalanine) is a chorisate mutase-prephenate dehydrogenase inhibitor. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-(Phenylacetyl)-L-phenylalanine | 98.43% | N-(Phenylacetyl)-L-phenylalanine (N-Phenylacetylphenylalanine) is an amino acid analog. N-(Phenylacetyl)-L-phenylalanine is produced via the enantioselective acylation of L-phenylalanine catalyzed by penicillin G acylase from Alcaligenes faecalis. N-(Phenylacetyl)-L-phenylalanine undergoes hydrolysis in aqueous media. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(1S,2S)-Bortezomib | 97.0% | (1S,2S)-Bortezomib (Compound Imp-D (1S,2S)) is a diastereomeric impurity of Bortezomib (HY-10227). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Hippuryl-L-phenylalanine | 98.65% | Hippuryl-L-phenylalanine is a substrate of carboxypeptidase. Carboxypeptidase is a protease enzyme that related with obesity, epilepsy and neurodegeneration. Hippuryl-L-phenylalanine can be used for the determination of carboxypeptidase activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
((Benzyloxy)carbonyl)-D-phenylalanine | 99.25% | ((Benzyloxy)carbonyl)-D-phenylalanine is a phenylalanine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Z-Phe-OH | 99.48% | Z-Phe-OH is a phenylalanine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glycyl-L-phenylalanine | 99.74% | Glycyl-L-phenylalanine is a phenylalanine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bortezomib impurity A | 99.75% | Bortezomib impurity A is a metabolite of the 20S proteasome inhibitor Bortezomib (HY-10227). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bortezomib impurity 12 | 99.12% | Bortezomib impurity 12 is an impurity of Bortezomib (HY-10227). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
